{
  "trial_id": "NCT00878826",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "age",
      "label": "met",
      "evidence": "32 years old"
    },
    {
      "criterion": "history of idiopathic thrombosis",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "history of thrombosis related to pregnancy or oral contraceptive use",
      "label": "not_met",
      "evidence": "no prior pregnancies"
    },
    {
      "criterion": "history of thrombosis accompanied by an underlying thrombophilia other than homozygous for the factor V Leiden mutation, heterozygous for both the factor V Leiden and the prothrombin G20210A mutation, or AT-III deficiency",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "without a history of thrombosis but who have an underlying thrombophilia and a strong family history of thrombosis",
      "label": "not_met",
      "evidence": "no family history mentioned"
    },
    {
      "criterion": "Known thrombophilia except for those listed above, with a history of adverse pregnancy outcome (APO) as defined by: \u22653 pregnancy losses in the 1st trimester, \u22652 pregnancy losses/stillbirth in 2nd trimester, \u22651 pregnancy loss/intrauterine fetal demise (IUFD) in the 3rd trimester, intrauterine growth restriction (IUGR), abruptio placentae, or severe pre-Eclampsia prior to 34 weeks gestation",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "history of thrombosis",
      "label": "not_met",
      "evidence": "no history mentioned"
    },
    {
      "criterion": "BMI >30",
      "label": "met",
      "evidence": "41.54 BMI"
    },
    {
      "criterion": "history of pregnancy loss or intrauterine fetal demise (IUFD)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "history of adverse pregnancy outcome (APO) as defined by: \u22653 pregnancy losses in the 1st trimester, \u22652 pregnancy losses/stillbirth in 2nd trimester, \u22651 pregnancy loss/intrauterine fetal demise (IUFD) in the 3rd trimester, intrauterine growth restriction (IUGR), abruptio placentae, or severe pre-Eclampsia prior to 34 weeks gestation",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "history of thrombosis related to pregnancy or oral contraceptive use",
      "label": "not_met",
      "evidence": "no prior pregnancies"
    },
    {
      "criterion": "history of idiopathic thrombosis",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Need for therapeutic-level anticoagulation as determined by physician",
      "label": "not_met",
      "evidence": "no mention of anticoagulation"
    },
    {
      "criterion": "Renal disease as defined by serum creatinine >1.0",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Weight >90kg",
      "label": "met",
      "evidence": "113 kg weight"
    },
    {
      "criterion": "Allergy to enoxaparin",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient is a 32-year-old obese woman with sleep apnea, PCO and dissatisfaction with her body shape. She has a history of high blood pressure and high cholesterol.",
  "_meta": {
    "topic_id": "36",
    "trial_id": "NCT00878826",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}